Recently, we discussed the role of zinc in optimizing hydroxychloroquine (HCQ) antiviral benefit. We’ve also been talking about profound potassium (K+) deficiency (hypokalemia) apparently being caused by CoV-2 hijacking of ACE2 receptors.
DetailsA new Harvard-led analysis finds that COVID-19 patients that live in areas with higher air pollution, such as New York City, have experienced a higher death-rate from the infection than those who lived in areas with cleaner air.
DetailsKetones (spefically beta-hydroxybutyrate) have shown to inhibit NLRP3 inflammasome activation, which is a key pathological mechanism in COVID-19.
DetailsIn a study of 175 COVID-positive patients in collaboration with Wenzhou Hospital in China, nearly all were identified as having hypokalemia (low serum potassium), likely due to the mechanisms of COVID-19 on ACE2 receptors and the renin-angiotensin system.
DetailsThere has been quite a bit of kerfuffle about the workhorse nutrient vitamin D. We are getting pinged daily on whether it should be used or avoided in the COVID19 pandemic. I believe this question was fueled by a recent write-up mentioning an in vitro study showing that D can up-regulate certain cytokines.
DetailsZinc is needed to slow viral RNA replication and it also regulates inflammatory cytokines. Anosmia and ageusia, as reported in COVID-19 and also common symptoms of flu, are classic signs of zinc defficiency.
DetailsQuercetin is a great flavonoid for many reasons: It’s a known anti-histamine. It’s considered essential in anti-aging protocols.
DetailsThe nose and sinuses are designed to protect us from viruses using small, finger-like projections called cilia that literally beat back infections. Cilia love humidity; when your sinuses and nasal passages get too dry, the cilia have a hard time doing their job and microbes get stuck in there. This is why pediatricians love humidifiers…
DetailsRole of Fat-Soluble Vitamins A and D in the Pathogenesis of Influenza: A New Perspective So here’s a topic I’ve wanted to dive into: the idea that it’s the ratio of D:A (D must be greater than A) for effective influenza tx/prophylaxis (and SARS in this hypothesis)… Vitamin A is essential, but if we dose…
DetailsWhile older individuals and those with underlying health conditions are still most at risk from COVID-19, more than one-third of those who have contracted the virus are aged 44 years and below. This age group also accounts for 20 percent of all hospitalizations and 12 percent of ICU admissions. None of us can be complacent…
DetailsDigestive symptoms may be the first signs of COVID-19 infection, for some people. While a dry cough and fever are typically conveyed as the symptoms to watch out for, this new study in the American Journal of Gastroenterology reports that some individuals may also/predominantly experience loss of appetite, loose stool, vomiting, and abdominal discomfort, together…
DetailsWhy are we considering palmitoylethanolamide (PEA) for COVID19? We have been interested in this molecule for years and have used in our allergy patients (it has well-documented mast cell stabilizing properties), in our pain patients and as influenza treatment and prophylaxis. In this most recent COVID19 pandemic, I think PEA is worth considering, although we…
DetailsDr. Manuel Salvadori, Functional Medicine physician in Italy, is addressing those with COVID19 in his practice using the following protocol. To quote him directly in response to me asking how his patients were faring with what he’s prescribing: “It’s not possible to evaluate results on the CoVID-19, as you can’t really tell if people are…
DetailsPromising pharmaceutical treatment (a repurposed flu drug) for early-stage COVID-19 could be available as early as May. Testing in 340 patients in Japan appears to reduce the median duration of infection from 11 to 4 days. 91% of those treated showed improved lung condition compared to 62% without treatment. Early intervention may be key as…
DetailsThe gut is a major site for IgE-producing B cells in peanut-allergic patients, defined for the first time by new research. The authors also found evidence suggesting that isotype switching can occur in GI tissue – including switching from IgA and IgG to IgE immunoglobulin types. This new understanding presents opportunities for future interventions to…
Details
